DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

NCT07545954 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Small-cell Lung Cancer
Small Cell Lung Cancer Extensive Stage

Interventions

DRUG: DSP-0390
DRUG: Atezolizumab

Sponsor

Washington University School of Medicine

Collaborators

[object Object]